跳至主要内容
临床试验/NCT07788534
NCT07788534招募中不适用

FeNO Fractional Exhaled Nitric Oxide Test as Significant Tool in Enhancing Asthma Treatment Management Among Children

King Faisal Specialist Hospital & Research Center0 个研究点目标入组 80 人开始时间: 2025年11月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
80
主要终点
correlations

研究概览

简要总结

This study aims to evaluate whether incorporating FeNO monitoring into routine pediatric asthma care improves clinical outcomes relative to a historical cohort managed without FeNO

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
6 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 6 to 14 years with a physician-diagnosed asthma.
  • Minimum of three months' follow-up at the pediatric respiratory clinic.
  • Availability of Asthma Control Test (ACT/C-ACT) scores and clinical data

排除标准

  • Presence of other chronic pulmonary diseases (e.g., cystic fibrosis).
  • Recent respiratory infections within four weeks prior to enrollment.
  • Current treatment with biologic agents affecting asthma inflammation.

结局指标

主要结局

correlations

时间窗: 6 MONTH

Establish correlations between FeNO levels and established asthma control markers such as ACT scores, eosinophils, and FEV1%.

Establish correlations between FeNO levels and established asthma control markers such as ACT scores, eosinophils, and FEV1%.

时间窗: 12 MONTH

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验